Evidence map›Paper›PMID 29670817›Full record

ArticleBrain and behavior2018

Dejerine-Sottas disease in childhood-Genetic and sonographic heterogeneity.

Sanne M R Hobbelink, Cain R Brockley, Rachel A Kennedy, Kate Carroll, Katy de Valle, Padma Rao, Mark R Davis, Nigel G Laing, Nicol C Voermans, Monique M Ryan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sanne M R HobbelinkNeurology Department Radboud University Medical Center Nijmegen The Netherlands.
Cain R BrockleyMedical Imaging Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.
Rachel A KennedyNeurology Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.
Kate CarrollNeurology Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.
Katy de ValleNeurology Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.
Padma RaoMedical Imaging Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.
Mark R DavisNeurogenetics Unit Department of Diagnostic Genomics Path West Laboratory Medicine QEII Medical Centre Nedlands WA Australia.
Nigel G LaingNeurogenetics Unit Department of Diagnostic Genomics Path West Laboratory Medicine QEII Medical Centre Nedlands WA Australia.
Nicol C VoermansNeurology Department Radboud University Medical Center Nijmegen The Netherlands.
Monique M RyanNeurology Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.
Eppie M YiuNeurology Department The Royal Children's Hospital Melbourne Parkville Vic. Australia.ORCID 0000-0001-6704-8402
Royal Children's Hospital · AURadboud University Nijmegen · NLQueen Elizabeth II Medical Centre · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The nerve sonographic features of Dejerine-Sottas disease (DSD) have not previously been described. Methods: This exploratory cross-sectional, matched, case-control study investigated differences in nerve cross-sectional area (CSA) in children with DSD compared to healthy controls and children with Charcot-Marie-Tooth disease type 1A (CMT1A). CSA of the median, ulnar, tibial, and sural nerves was measured by peripheral nerve ultrasound. The mean difference in CSA between children with DSD, controls, and CMT1A was determined individually and within each group. Results: Five children with DSD and five age- and sex-matched controls were enrolled. Data from five age-matched children with CMT1A was also included. Group comparison showed no mean difference in nerve CSA between children with DSD and controls. Individual analysis of each DSD patient with their matched control indicated an increase in nerve CSA in three of the five children. The largest increase was observed in a child with a heterozygous Conclusions: Changes in nerve CSA on ultrasonography in children with DSD differ according to the underlying genetic etiology, confirming the variation in underlying pathobiologic processes and downstream morphological abnormalities of DSD subtypes. Nerve ultrasound may assist in the clinical phenotyping of DSD and act as an adjunct to known distinctive clinical and neurophysiologic findings of DSD subtypes. Larger studies in DSD cohorts are required to confirm these findings.

Indexed as

Case-Control StudiesCharcot-Marie-Tooth DiseaseChildChild, PreschoolCross-Sectional StudiesEarly Growth Response Protein 2FemaleHereditary Sensory and Motor NeuropathyHeterozygoteHumansMaleMedian NerveMyelin P0 ProteinMyelin ProteinsNeural ConductionOrgan SizeEarly Growth Response Protein 2EGR2 protein, humanMPZ protein, humanMyelin P0 ProteinMyelin ProteinsPMP22 protein, humanCharcot–Marie–Tooth diseaseDejerine–Sottas diseasepediatricperipheral neuropathyultrasound

Identifiers

PMID29670817
PMCPMC5893341
OpenAlexW2884297033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.